CTI BioPharma (CTIC) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Financial Fact:
Net loss attributable to CTI: -29.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net loss attributable to CTI: -29.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
CTI BioPharma (NASDAQ: CTIC) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $8.73 million.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
